A carregar...
The evolving role of immuno‐oncology for the treatment of head and neck cancer
Monoclonal antibodies (mAbs) that target immune co‐signaling pathways have the potential to enable immune mediated tumor eradication. While early adoption of these agents for the treatment of advanced squamous cell carcinoma of the head and neck (SCCHN) has produced some astounding clinical successe...
Na minha lista:
| Publicado no: | Laryngoscope Investig Otolaryngol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6383301/ https://ncbi.nlm.nih.gov/pubmed/30828620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/lio2.235 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|